TAOPING INC (TAOP)

VGG8675V1278 - Common Stock

0.799  +0.07 (+9.9%)

After market: 0.8634 +0.06 (+8.06%)

Fundamental Rating

1

TAOP gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 85 industry peers in the IT Services industry. Both the profitability and financial health of TAOP have multiple concerns. TAOP does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

TAOP had negative earnings in the past year.
TAOP had a negative operating cash flow in the past year.
TAOP had negative earnings in each of the past 5 years.
In the past 5 years TAOP always reported negative operating cash flow.

1.2 Ratios

TAOP has a Return On Assets (-2.13%) which is in line with its industry peers.
TAOP has a Return On Equity (-5.47%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.13%
ROE -5.47%
ROIC N/A
ROA(3y)-15.81%
ROA(5y)-22.75%
ROE(3y)-43.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 22.91%, TAOP is doing worse than 70.24% of the companies in the same industry.
TAOP's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for TAOP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.28%
GM growth 5Y-13.42%

1

2. Health

2.1 Basic Checks

TAOP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TAOP has more shares outstanding
TAOP has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, TAOP has a worse debt to assets ratio.

2.2 Solvency

TAOP has an Altman-Z score of -7.02. This is a bad value and indicates that TAOP is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of TAOP (-7.02) is worse than 94.05% of its industry peers.
TAOP has a Debt/Equity ratio of 0.70. This is a neutral value indicating TAOP is somewhat dependend on debt financing.
TAOP's Debt to Equity ratio of 0.70 is in line compared to the rest of the industry. TAOP outperforms 44.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Altman-Z -7.02
ROIC/WACCN/A
WACC7.93%

2.3 Liquidity

A Current Ratio of 1.26 indicates that TAOP should not have too much problems paying its short term obligations.
The Current ratio of TAOP (1.26) is worse than 60.71% of its industry peers.
TAOP has a Quick Ratio of 1.20. This is a normal value and indicates that TAOP is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.20, TAOP is not doing good in the industry: 61.90% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.2

3

3. Growth

3.1 Past

TAOP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 87.03%, which is quite impressive.
Looking at the last year, TAOP shows a very strong growth in Revenue. The Revenue has grown by 59.43%.
Measured over the past years, TAOP shows a quite strong growth in Revenue. The Revenue has been growing by 13.40% on average per year.
EPS 1Y (TTM)87.03%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q115.11%
Revenue 1Y (TTM)59.43%
Revenue growth 3Y51.55%
Revenue growth 5Y13.4%
Revenue growth Q2Q45.04%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

TAOP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TAOP is valued cheaper than 96.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.71

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for TAOP!.
Industry RankSector Rank
Dividend Yield N/A

TAOPING INC

NASDAQ:TAOP (5/17/2024, 7:00:01 PM)

After market: 0.8634 +0.06 (+8.06%)

0.799

+0.07 (+9.9%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.61M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.13%
ROE -5.47%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 22.91%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.26
Quick Ratio 1.2
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)87.03%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)59.43%
Revenue growth 3Y51.55%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y